All news

Bristol Myers Squibb Company $BMY Stock: Pzena Investment Management LLC Lowers Holdings

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Pzena Investment Management LLC significantly reduced its stake in Bristol Myers Squibb (NYSE:BMY) by 16.2% in the third quarter, selling over 2.7 million shares. Despite this reduction, Bristol Myers Squibb remains a significant portion of Pzena's portfolio. Other institutional investors, such as BlackRock Inc. and State Street Corp, increased their holdings in the biopharmaceutical company during the second quarter.

Read original source

BMY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.